
Frequent recurrences and the potential for progression of non‐muscle‐invasive bladder cancer (NMIBC) demand close surveillance. This prospective study evaluated the performance of Xpert Bladder Cancer Monitor (Xpert) test as a predictor of tumor recurrence...
Like
Save
Share